DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Phase 4

Not yet recruiting

Conditions: Thyroid Neoplasm Follicular
Bone Metastases

Interventions: Drug: Sr-89

First Posted Date: 2022-07-20

Last Posted Date: 2022-07-20

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 20

Registration Number: NCT05466812

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, China

Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients

Phase 4

Not yet recruiting

Conditions: Shock

Interventions: Drug: Compound sodium acetate ringer injection
Drug: Albumin

First Posted Date: 2022-07-19

Last Posted Date: 2022-07-19

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 500

Registration Number: NCT05463471

Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study

Phase 4

Conditions: Overactive Bladder

Interventions: Drug: mirabegron

First Posted Date: 2022-07-11

Last Posted Date: 2022-07-11

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 600

Registration Number: NCT05452434

Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes

Conditions: Acute Respiratory Failure
Acute Respiratory Distress Syndrome

Interventions: Diagnostic Test: Integrated Transcriptomics, Metabolomics, and Lipidomics Profiling

First Posted Date: 2022-07-11

Last Posted Date: 2022-07-11

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 200

Registration Number: NCT05451342

Locations: 🇨🇳
PUMC, Beijing, Beijing, China
🇨🇳
Yingying Yang, Beijing, Beijing, China

Lenalidomide in the Treatment of Mucosal Behçet's Syndrome

Not Applicable

Recruiting

Conditions: Oral Ulcer

Interventions: Drug: Lenalidomide 10 mg

First Posted Date: 2022-07-08

Last Posted Date: 2025-01-10

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 42

Registration Number: NCT05449548

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer

Phase 2

Recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Furmonertinib

First Posted Date: 2022-07-06

Last Posted Date: 2023-02-16

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 114

Registration Number: NCT05445310

Locations: 🇨🇳
Peking Union Medical College Hopital, Beijing, China

Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL

Phase 1

Recruiting

Conditions: Peripheral T-cell Lymphoma
Treatment

Interventions: Drug: liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin

First Posted Date: 2022-07-01

Last Posted Date: 2022-07-01

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 60

Registration Number: NCT05441761

Locations: 🇨🇳
Beijing Hospital, Beijing, China
🇨🇳
Beijing Luhe Hospital, Capital Medical University, Beijing, China
🇨🇳
Peking Union Medical College Hospital, Beijing, China

and more 2 locations

Effect of Initial Empirical PEEP Setting on the Esophageal Pressure-guided PEEP Titration in ARDS

Completed

Conditions: PEEP, Occult
ARDS, Human
Esophageal and Pleural Pressure

Interventions: Other: PEEP adjustment

First Posted Date: 2022-07-01

Last Posted Date: 2022-07-01

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 18

Registration Number: NCT05442073

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Gastrointestinal Endoscopy Artificial Intelligence Cloud Platform in Gastrointestinal Endoscopy Screening

Not Applicable

Conditions: Artificial Intelligence
Diagnoses Disease
Endoscopy
Quality Control

Interventions: Device: The Artificial intelligence Cloud Platform

First Posted Date: 2022-06-28

Last Posted Date: 2022-07-12

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 2000

Registration Number: NCT05435872

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, China

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Not Applicable

Completed

Conditions: Clear Cell Renal Cell Carcinoma

Interventions: Drug: 68Ga-P16-093
Drug: 18F-FDG

First Posted Date: 2022-06-27

Last Posted Date: 2022-11-03

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 42

Registration Number: NCT05432947

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy